Mission Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $830K | Buy |
1,577
+149
| +10% | +$83.6K | 0.01% | 532 |
|
|
2026
Q1 | $802K | Buy |
1,428
+4
| +0.3% | +$2.56K | 0.02% | 368 |
|
|
2025
Q4 | $964K | Buy |
1,424
+7
| +0.5% | +$4.77K | 0.02% | 341 |
|
|
2025
Q3 | $906K | Sell |
1,417
-3
| -0.2% | -$1.82K | 0.02% | 352 |
|
|
2025
Q2 | $762K | Sell |
1,420
-249
| -15% | -$119K | 0.02% | 378 |
|
|
2025
Q1 | $701K | Sell |
1,669
-1
| -0.1% | -$434 | 0.02% | 377 |
|
|
2024
Q4 | $691K | Sell |
1,670
-215
| -11% | -$94.3K | 0.02% | 359 |
|
|
2024
Q3 | $952K | Sell |
1,885
-47
| -2% | -$22.8K | 0.02% | 302 |
|
|
2024
Q2 | $941K | Buy |
1,932
+56
| +3% | +$28.1K | 0.02% | 281 |
|
|
2024
Q1 | $1.01M | Buy |
1,876
+13
| +0.7% | +$7.1K | 0.03% | 293 |
|
|
2023
Q4 | $1.03M | Buy |
1,863
+7
| +0.4% | +$3.29K | 0.03% | 231 |
|
|
2023
Q3 | $811K | Buy |
1,856
+104
| +6% | +$51.9K | 0.03% | 255 |
|
|
2023
Q2 | $880K | Buy |
1,752
+6
| +0.3% | +$2.88K | 0.03% | 246 |
|
|
2023
Q1 | $873K | Buy |
1,746
+20
| +1% | +$9.57K | 0.04% | 247 |
|
|
2022
Q4 | $704K | Buy |
1,726
+2
| +0.1% | +$776 | 0.03% | 264 |
|
|
2022
Q3 | $562K | Buy |
1,724
+21
| +1% | +$7.71K | 0.03% | 279 |
|
|
2022
Q2 | $597K | Buy |
1,703
+92
| +6% | +$37.5K | 0.03% | 275 |
|
|
2022
Q1 | $881K | Buy |
1,611
+148
| +10% | +$77.9K | 0.04% | 221 |
|
|
2021
Q4 | $963K | Buy |
1,463
+24
| +2% | +$15.1K | 0.04% | 199 |
|
|
2021
Q3 | $895K | Sell |
1,439
-30
| -2% | -$20.2K | 0.05% | 196 |
|
|
2021
Q2 | $928K | Sell |
1,469
-76
| -5% | -$42K | 0.05% | 180 |
|
|
2021
Q1 | $756K | Buy |
1,545
+1
| +0.1% | +$501 | 0.04% | 187 |
|
|
2020
Q4 | $772K | Buy |
1,544
+319
| +26% | +$143K | 0.05% | 164 |
|
|
2020
Q3 | $482K | Hold |
1,225
| – | – | 0.04% | 208 |
|
|
2020
Q2 | $404K | Sell |
1,225
-25
| -2% | -$7.24K | 0.03% | 206 |
|
|
2020
Q1 | $303K | Hold |
1,250
| – | – | 0.03% | 208 |
|
|
2019
Q4 | $326K | Buy |
1,250
+50
| +4% | +$13.2K | 0.03% | 241 |
|
|
2019
Q3 | $326K | Hold |
1,200
| – | – | 0.03% | 216 |
|
|
2019
Q2 | $330K | Hold |
1,200
| – | – | 0.04% | 227 |
|
|
2019
Q1 | $268K | Hold |
1,200
| – | – | 0.03% | 250 |
|
|
2018
Q4 | $223K | Hold |
1,200
| – | – | 0.03% | 244 |
|
|
2018
Q3 | $300K | Hold |
1,200
| – | – | 0.04% | 211 |
|
|
2018
Q2 | $262K | Hold |
1,200
| – | – | 0.04% | 213 |
|
|
2018
Q1 | $230K | Buy |
+1,200
| New | +$221K | 0.04% | 195 |
|
Other funds holding IDXX
Mission Wealth Management's IDXX Position: Q2 2026 in Review
Mission Wealth Management increased its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, buying an estimated $83.6K and bringing the position to 1,577 shares worth $830K. The position accounts for 0.01% of the portfolio, ranked #532.
Mission Wealth Management first reported a position in IDXX in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.03M in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Mission Wealth Management held 1,577 shares of Idexx Laboratories worth $830K as of Q2 2026.
- Mission Wealth Management bought 149 Idexx Laboratories shares in Q2 2026, an estimated $83.6K.
- Idexx Laboratories made up 0.01% of Mission Wealth Management's portfolio in Q2 2026, its #532 holding.
- Mission Wealth Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 34 quarters since.
- Mission Wealth Management's Idexx Laboratories position peaked at $1.03M in Q4 2023.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.